Elements of an Effective Change Control System

An effective change control system is one of the cornerstones of a productive organizational quality system. Change control can be instrumental in ensuring continuous control over changes to facilities, equipment, processes, specifications, and laboratory operations, etc.

The importance of change control is emphasized by how it is stressed in regulatory inspections (FDA, EU, TGA, etc.) and in regulatory requirements. There are specific change control elements in cGMPs, ICH, and ISO requirements. All these are critical components of the latest regulatory guidelines on the implementation of quality systems.

This webinar will help attendees understand the critical role that change control has in the successful implementation of a quality system and how it can be a vital element in achieving quality and ensuring regulatory compliance.

• Change control’s role in an effective quality system
• Specific regulatory requirement for change control
• ICH guidelines and Good Manufacturing Practices
• Guidelines on change control’s role in regulatory inspections
• Specific design requirements for a change control system
• Key aspects of the role and key players involved in a change control system
• Common problems encountered in change control
• Recent regulatory trends and observations.

• Pharmaceutical professionals involved in the manufacture of products
• API and excipients providers
• Service providers
• All levels of management
• Change control professionals
• Quality professionals

Instructor Profile:

Michael Ferrante

President, Quality and Compliance Associates LLC

Mr. Ferrante is President of Quality and Compliance Associates LLC and has over 40 years experience in the pharmaceutical and biotechnology fields. This experience encompasses quality systems, laboratories, R&D, clinical QA, validation, manufacturing/operations, regulatory affairs, and facilities covering all dosage forms.

During his career, Mr. Ferrante has successfully dealt with over 100 inspections by regulatory agencies, resolved warning letters, prepared and controlled compliance plans at both a site and corporate level. These interactions have occurred both domestically (US) and internationally, since he has dealt in global operations in countries such as Australia, Canada, the Netherlands, Sweden, Brazil, UK, Ireland, Germany, France, Switzerland, Italy, the Czech Republic, India, China, Malaysia, and Thailand.

He has held middle to senior management positions in startup to Fortune 100 companies up to the level of VP of Quality Systems and Compliance. Mr. Ferrante has been asked to give presentations on a number of regulatory and quality topics by the American Society for Quality, the Parenteral Drug Association, International Society of Pharmaceutical Engineers, and the Institute for Validation Technology. He has published articles in the Journal of Validation and Journal of Compliance.